全文获取类型
收费全文 | 617592篇 |
免费 | 43034篇 |
国内免费 | 16346篇 |
专业分类
耳鼻咽喉 | 7102篇 |
儿科学 | 16791篇 |
妇产科学 | 9935篇 |
基础医学 | 48100篇 |
口腔科学 | 12667篇 |
临床医学 | 77657篇 |
内科学 | 84626篇 |
皮肤病学 | 7709篇 |
神经病学 | 38882篇 |
特种医学 | 21735篇 |
外国民族医学 | 56篇 |
外科学 | 69497篇 |
综合类 | 79791篇 |
现状与发展 | 41篇 |
一般理论 | 35篇 |
预防医学 | 58476篇 |
眼科学 | 9801篇 |
药学 | 65820篇 |
635篇 | |
中国医学 | 42064篇 |
肿瘤学 | 25552篇 |
出版年
2023年 | 8553篇 |
2022年 | 13315篇 |
2021年 | 24835篇 |
2020年 | 21132篇 |
2019年 | 27225篇 |
2018年 | 23237篇 |
2017年 | 20790篇 |
2016年 | 20650篇 |
2015年 | 22459篇 |
2014年 | 42475篇 |
2013年 | 44061篇 |
2012年 | 41080篇 |
2011年 | 39303篇 |
2010年 | 33228篇 |
2009年 | 31452篇 |
2008年 | 29762篇 |
2007年 | 30288篇 |
2006年 | 26343篇 |
2005年 | 20358篇 |
2004年 | 14537篇 |
2003年 | 12704篇 |
2002年 | 10262篇 |
2001年 | 9066篇 |
2000年 | 7489篇 |
1999年 | 6016篇 |
1998年 | 5311篇 |
1997年 | 4936篇 |
1996年 | 4255篇 |
1995年 | 4461篇 |
1994年 | 4210篇 |
1993年 | 3407篇 |
1992年 | 3621篇 |
1991年 | 3134篇 |
1990年 | 2984篇 |
1989年 | 2764篇 |
1988年 | 2575篇 |
1987年 | 2267篇 |
1986年 | 2034篇 |
1985年 | 5431篇 |
1984年 | 6416篇 |
1983年 | 4514篇 |
1982年 | 5112篇 |
1981年 | 4800篇 |
1980年 | 4289篇 |
1979年 | 3833篇 |
1978年 | 3279篇 |
1977年 | 2647篇 |
1976年 | 2782篇 |
1975年 | 2010篇 |
1974年 | 1822篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
991.
《Clinical neurophysiology》2021,132(10):2519-2531
ObjectiveTo test the hypothesis that intermittent theta burst stimulation (iTBS) variability depends on the ability to engage specific neurons in the primary motor cortex (M1).MethodsIn a sham-controlled interventional study on 31 healthy volunteers, we used concomitant transcranial magnetic stimulation (TMS) and electroencephalography (EEG). We compared baseline motor evoked potentials (MEPs), M1 iTBS-evoked EEG oscillations, and resting-state EEG (rsEEG) between subjects who did and did not show MEP facilitation following iTBS. We also investigated whether baseline MEP and iTBS-evoked EEG oscillations could explain inter and intraindividual variability in iTBS aftereffects.ResultsThe facilitation group had smaller baseline MEPs than the no-facilitation group and showed more iTBS-evoked EEG oscillation synchronization in the alpha and beta frequency bands. Resting-state EEG power was similar between groups and iTBS had a similar non-significant effect on rsEEG in both groups. Baseline MEP amplitude and beta iTBS-evoked EEG oscillation power explained both inter and intraindividual variability in MEP modulation following iTBS.ConclusionsThe results show that variability in iTBS-associated plasticity depends on baseline corticospinal excitability and on the ability of iTBS to engage M1 beta oscillations.SignificanceThese observations can be used to optimize iTBS investigational and therapeutic applications. 相似文献
992.
993.
994.
995.
996.
997.
998.
Yu Fan Xiaoling Liao Yuesong Pan Kehui Dong Yilong Wang Yongjun Wang 《Journal of stroke and cerebrovascular diseases》2019,28(1):220-226
Background
The intravenous thrombolysis (IVT) with recombinant tissue plasminogen activator (rt-PA) therapy is safe and efficient during the treatment of acute ischemic stroke. Nonetheless, the different outcomes among various stroke subgroups have limited data with regard to the safety and efficacy of cryptogenic stroke (CS). The present study compared the safety and efficacy when IVT with rt-PA was used for the treatment of CS and the other stroke subtypes.Methods
This study classified the IVT with rt-PA patients within 4.5 hours after stroke onset, based on the trial of ORG 10172 in acute stroke treatment criteria in terms of diagnostic evaluation. The data were obtained from the Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China database, a large multicenter prospective registry. A multivariable logistic regression model was employed to compare the differences between the subtypes in symptomatic intracerebral hemorrhage (sICH) within 7 days and studied the mortality and the outcome during 90 days.Results
In total, 1118 patients were recruited; of these, 131 (11.7%) suffered from CS and 987 (88.3%) with the other etiology. In the CS group, patients were younger than those in the other etiology groups (P < .001). Moreover, it had a lower prevalence of previous stroke (P?=?.0117), receiving antiplatelet drug in 24 hours prior to thrombolysis (P?=?.0017), and functional independence (mRS > 1 before stroke, P?=?.003). The CS group had lower blood pressure (systolic blood pressure P?=?.0001; diastolic blood pressure; P?=?.0212) before thrombolysis, atrial fibrillation (P < .001), and diabetes mellitus (P?=?.0005). Transient ischemic attack, hypertension, hyperlipidemia, blood glucose, receiving anticoagulants in 24 hours prior to thrombolysis, and standard dosage of rt-PA were equally distributed in both groups. After the adjustment of confounders between the CS and the other subgroups, no obvious differences were observed in sICH rate and mortality (P > .05) The CS patients exhibited excellent recovery (mRS, 0-1; 63.78%) and functional independence (mRS, 0-2; 74.8%) than the large artery atherosclerosis patients.Conclusions
IVT with rt-PA is a safe and effective method for the treatment of CS patients. 相似文献999.
Roberto V.P. Ribeiro Mitesh V. Badiwala Danny Ramzy Laura C. Tumiati Vivek Rao 《The Journal of thoracic and cardiovascular surgery》2019,157(2):615-625.e1
Objective
Hypertonic saline (HTS) has potent immune and vascular effects. We assessed recipient pretreatment with HTS on allograft function in a porcine model of heart transplantation and hypothesized that HTS infusion would limit endothelial and left ventricular (LV) dysfunction following transplantation.Methods
Heart transplants were performed after 6 hours of cold ischemic storage. Recipient pigs were randomized to treatment with or without HTS (7.5% NaCl) before cardiopulmonary bypass (CPB). Using a myograft apparatus, coronary artery endothelial-dependent (Edep) and -independent (Eind) relaxation was assessed. LV performance was determined using pressure-volume loop analysis. Pulmonary interleukin (IL)-2, IL-6, and tumor necrosis factor (TNF)-α expression was measured.Results
Weaning from CPB and LV performance after transplantation were improved in HTS-treated animals. Successful weaning from CPB was greater in the HTS-treated hearts (8 of 8 vs 2 of 8; P < .05). Mean LV functional recovery was improved in the HTS-treated animals, as assessed by preload recruitable stroke work (65 ± 10% vs 27 ± 10%; P < .001) and end-systolic elastance (55 ± 7% vs 37 ± 4%; P < .001). Treatment with HTS resulted in improved Edep (mean maximum elastance [Emax], 56 ± 5% vs 37 ± 7%; P < .001) and Eind (mean Emax%, 77 ± 6% vs 52 ± 4%; P < .001) vasorelaxation compared with control. Pulmonary expression of IL-2, IL-6, and TNF-α increased following transplantation, whereas HTS therapy attenuated IL production (P < .001). Transplantation increased plasma TNF-α levels and LV TNF-α expression, whereas HTS prevented this up-regulation (P < .001).Conclusions
Recipient HTS pretreatment preserves allograft vasomotor and LV function, and HTS therapy limits CPB-induced injury. HTS may be a novel recipient intervention to prevent graft dysfunction. 相似文献1000.